In lung cancer, a detailed analysis of MMPs and TIMPs was presented by Iniesta et al., who demonstrated that MMP-9 can be used as a factor in potentially unfavorable clinical evolution and TIMP-1 bears features of an independent prognostic factor in lung cancer [30]. The gene discussed is MMP9; the disease is lung cancer.